RWA
ARLZ

Ropes Wealth Advisors’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Ropes Wealth Advisors’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-400
Closed – – 609
2018
Q2 		$0 Buy
+400
New +$328 ﹤0.01% 619

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Ropes Wealth Advisors's ARLZ Position: Q3 2018 in Review

Ropes Wealth Advisors sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 400 shares.

Ropes Wealth Advisors first reported a position in ARLZ in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Ropes Wealth Advisors reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Ropes Wealth Advisors sold 400 Aralez Pharmaceuticals Inc. shares in Q3 2018.
  • Ropes Wealth Advisors first reported a position in Aralez Pharmaceuticals Inc. in Q2 2018 and held it in 1 quarter.
  • Ropes Wealth Advisors's Aralez Pharmaceuticals Inc. position peaked at $0 in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Ropes Wealth Advisors's 13F filing for Q3 2018, filed 30 Oct 2018.